Abstract
The clinical effectiveness of heart valve replacement surgery has been well documented. Mechanical and homograft valves are used routinely for replacement of damaged heart valves. Homograft valves are produced in our country but we import the mechanical valves. To our knowledge the cost-effectiveness of homograft valve has not been assessed. The objective of the present study was to compare the cost-effectiveness of homograft valve replacement with mechanical valve replacement surgery. Our samples were selected from 200 patients that underwent homograft and mechanical heart valve replacement surgery in Imam-Khomeini hospital (2000–2005). In each group we enrolled 30 patients. Quality of life was measured using the SF-36 questionnaire and utility was measured in quality-adjusted life years (QALYs). For each group we calculated the price of heart valve and hospitalization charges. Finally the cost-effectiveness of each treatment modalities were summarized as costs per QALYs gained. Forty male and twenty female participated in the study. The mean score of quality of life was 66.06 (SD = 9.22) in homograft group and 57.85 (SD = 11.30) in mechanical group (P < 0.05). The mean QALYs gained in homograft group was 0.67 more than mechanical group. The incremental cost-effectiveness ratio (ICER) revealed a cost savings of 1,067 US$ for each QALY gained in homograft group. Despite limitation of this introductory study, we concluded that homograft valve replacement was more effective and less expensive than mechanical valve. These findings can encourage healthcare managers and policy makers to support the production of homograft valves and allocate more recourse for developing such activities.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Blomqvist A (2002) QALYs, standard gambles and the expected budget constraint. J Health Econ 21:181–195
Clarke DR (2002) Presidential address: value, viability and valves. J Thorac Cardiovasc Surg 124(1):1–6
Dabbagh A, Sarraf Zadegan N, Bani Fatemi V, Habibi HR, Rafiei M (2003) Costs of therapeutic modalities of cardiovascular patients in Isfahan university hospitals. HAKIM Res J 2(6):19–25
Dayton JD, Kanter KR, Vincent RN, Mahle WT (2006) Cost-effectiveness of pediatric heart transplantation. J Heart Lung Transplant 25(4):409–415
Eichler HG, Kong SX, Gerth WC, Mavros P, Jönsson B (2004) Use of cost-effectiveness analysis in health-care resource allocation decision-making: how are cost-effectiveness thresholds expected to emerge? Value Health 7(5):518–528
Kaplan RM (2002) Quality of life: an outcomes perspective. Arch Phys Med Rehabil 83(2):S44–S50
Kawachi I (1989) QALYs and justice. Health Policy 13(2):115–120
Kontodimopoulos N, Niakas D (2008) An estimate of lifelong costs and QALYs in renal replacement therapy based on patients’ life expectancy. Health Policy 86:85–96
Lever CG, Ross DB, Page LK, La Prairie A, Molyneaux M, Murphy DA (1995) Cost-effectiveness and efficacy of an on-site homograft heart valve bank. Can J Surg 38(6):492–496
Levin LA, Jönsson B (1992) Cost-effectiveness of thrombolysis- a randomized study of intravenous rt-PA in suspected myocardial infarction. Eur Heart J 13(1):2–8
Loomes G, McKenzie L (1989) The use of QALYs in health care decision making. Soc Sci Med 28(4):299–308
Maliwa MA, Heijden MG, Bots ML, Hout BA, Casselman FP, Swieten HV, Vermeulen FEE (2003) Quality of life and NYHA class 30 years after mechanical aortic valve replacement. Cardiovasc Surg 11(5):381–387
Marshal PA (1990) Cultural influences on perceived quality of life. Semin Oncol Nurs 6(4):278–284
McGregor M (2003) Cost-utility analysis: use QALYs only with great caution. CMAJ 168(4):433–434
Otto CM, Bonow RO (2008) Valvular heart disease. 62th Chapter. In: Libby P, Bonow RO, MannZipes DP DL, Zipes DP (eds) Braunwald’s heart disease: a textbook of cardiovascular medicine, 8th edn. Elsevier Inc, Philadelphia, USA
Parande A, SiratiNir M, Khaghanizadeh M, Karimizarchi AA (2007) Comparison the effect of training of conflict resolution and relaxation on quality of life’s spouses of war veterans affected Post traumatic stress disorder with major depression disorder. Q J Fundam Ment Health 9(33):67–76
Rahnavard Z, Zolfaghari M, Kazemnejad A, Hatamipour Kh (2006) An investigation of quality of life and factors affecting it in the patients with congestive heart failure. J Fac Nurs Midwifery 1(12):77–86
Salehi M, Sattarzadeh R, Soleimani AA, Radmehr H, Mirhosseini J, Sanatkarfar M (2007) The ross operation: clinical results and echocardiographic findings. Asian Cardiovasc Thorac Ann 15:30–34
Sattarzadeh R, Radmehr H, Soleimani A, Salehi M (2008) Pulmonary allograft stenosis after ross procedure: risk factors. Tehran Univ Med J 4(66):257–261
Taghaddosi M, Abdar Esfahani M, Mousavi SG (2005) Difficulties of patients with replaced heart valve in Kashan, 2001. Feyz, Kashan Univ Med Sci Health Serv 34(9):63–69
Tilford JM (2002) Cost-effectiveness analysis and emergency medical services for children: issue and applications. Ambul Pediatr 2(4):330–336
Wu YX, Jin R, Gao G, Grunkemeier GL, Starr A (2007) Cost-effectiveness of aortic valve replacement therapy in the elderly: an introductory study. J Thorac Cardiovasc Surg 133:608–613
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Yaghoubi, M., Aghayan, H.R., Arjmand, B. et al. Cost-effectiveness of homograft heart valve replacement surgery: an introductory study. Cell Tissue Bank 12, 153–158 (2011). https://doi.org/10.1007/s10561-009-9165-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10561-009-9165-9